LAROKSIN table. 150 mg. 30 table
LAROKSIN table. 150 mg. 30 table
LAROKSIN SR WHAT IS AND WHAT IT IS USED
Laroksin SR belongs to a group of medicines called antidepressants are used to relieve depressive symptoms.
The drug has protivostrahovi properties and is used to treat anxiety conditions. Laroksin SR applies to:
relieve symptoms of depression, incl. depression associated with anxiety as patients on inpatient and outpatients at.
to prevent worsening depression or the emergence of new depressive episodes.
to treat specific symptoms of anxiety disorders, including. and continuous administration.
For the treatment of social anxiety disorder and generalized anxiety disorder.
WHAT YOU NEED TO KNOW BEFORE TREATMENT WITH SR LAROKSIN
Laroksin SR does not apply to:
Pregnancy (unless your doctor has told you so) and lactation;
Known hypersensitivity to the active substance or excipients;
Concomitant use of the product with other antidepressants known as MAO inhibitors or taking a MAO inhibitor in the last two weeks before starting treatment with Laroksin SR;
If you are feeling depressed and / or have anxiety disorders may occasionally thoughts of harming or killing themselves. These may be increased when first starting antidepressants, since these medicines all take time to start running - usually about two weeks but sometimes longer.
You may be more likely to think like this:
If you have previously had thoughts about killing or harming yourself;
If you are a young man: Clinical studies have shown an increased risk of suicide-related behaviors in young people (under 25 years) with psychiatric conditions who were treated with an antidepressant.
If at any time you get any thoughts of harming or killing yourself, contact your doctor or go to hospital!
You may find it helpful to tell a relative or close friend that you are depressed or have an anxiety disorder, and ask them to read this leaflet. You might ask them to tell you if they think your depression or anxiety is getting worse, or are worried about changes in your behavior.
Age less than 18 years.
You should consult with your doctor or pharmacist if:
You suffer from liver or kidney disease, as prescribed dose can be reduced;
If you suffer from epilepsy. Your doctor will closely monitor you throughout the course of treatment.
Application Laroksin SR and intake of foods and beverages
The product should be taken with food.
Pregnancy and lactation
Before taking any medicines, check with your doctor or pharmacist
There is no proven safety during pregnancy. SR Laroksin not be used during pregnancy unless clearly necessary. Use of the product in late stages of pregnancy or antenatal period should be given to the possibility of occurrence of withdrawal syndrome in the neonate. In neonates whose mothers received the product in the last three months of pregnancy were observed respiratory failure or prolonged hospital stay.
There is evidence to move the product into breast milk. In such cases, you must decide whether or not a treatment or to stop breastfeeding.
Driving and operating machinery
Although Laroksin SR showed no impairment of psychomotor, cognitive, or common behaviors in healthy volunteers, any psychoactive drugs may impair judgment, thinking or motor responses. Patients should be warned of this and be careful in the use of machines whose use carries some risk, incl. and cars.
Taking other medicines
Please tell your doctor or pharmacist if you or your child are taking or have recently taken any other medicines, even if they have not been prescribed by a doctor
HOW TO USE LAROKSIN SR
Always Laroksin SR as your doctor!
The usual dose of Laroksin SR for the treatment of depression is 75 mg daily, administered once daily. In need of additional therapeutic effect after two-week course of treatment, the dose may be increased to 150 mg daily, administered once daily. In case you require the use of a higher dose, the latter may be increased to 225 mg, taken once daily in patients with moderate to severe depression and 375 mg daily in patients with severe depression. Dosage adjustments should be made at intervals of about two weeks, but not less than four days.
At a dose of 75 mg antidepressant activity of the product is proyavyava_sled carrying about two weeks of treatment.
The usual dose of Laroksin SR for the treatment of specific anxiety disorders, including social anxiety disorder is 75 mg, taken once daily. If necessary, further clinical response after two weeks of treatment, the dose may be increased to 150 mg, taken once daily. In case you require the use of a higher dose, the latter may be increased to 225 mg daily mg in patients with severe depression. Dosage adjustments should be made at intervals of about two weeks or more, but not less than four days.
At a dose of 75 mg anxiolytic activity of the product occurs after about one week of treatment. For patients who do not respond to treatment with a dose of 75 mg once daily, the dose may be increased to a maximum of 225 mg daily. The dose may be increased by not more than 75 mg daily as changes need to be made at intervals of about two weeks or more, but not less than four days. Recommended intake of it while eating.
Laroksin SR should be administered once daily at approximately the same time of day, morning or evening. Patients with impaired renal function
For patients with renal impairment and glomerular filtration rate of 10 to 70 ml / min, the daily dose Laroksin SR should be reduced by 25-50%. In hemodialysis patients, the daily dose should be reduced by 50%. Medicines should not be taken during hemodialysis.
Patients with impaired hepatic function
In patients with moderate hepatic impairment, the daily dose should be reduced by 50%. Some patients may require a dose reduction of more than 50%.
Usually no need for dose adjustment in the elderly. However, caution is required in such cases (because renal impairment). It should be the lowest effective dose, if necessary by increasing the dose the patient should be under observation.
Children and adolescents
There is no proven effective Laroksin SR in patients under 18 years of age. Maintenance and continuous treatment
It is recognized that acute episodes of major depression require continuous treatment for several months or more. Patients with specific anxiety disorders, incl. social anxiety disorder often suffer for years in this case involves the delivery of treatment.
Proven performance is Laroksin SR prolonged treatment (up to 12 months for depression and b months for specific anxiety disorders, incl. Social anxiety disorder). Usually, when the drug is used to prevent deterioration of depressive episode or onset of new depressive episodes, the dosing regime is the same as that which was used in the initial therapy.
The physician should periodically reassess each patient appropriateness of continued treatment with Laroksin SR. Discontinuation of treatment
Sudden discontinuation should be avoided. After treatment for more than six weeks a gradual reduction of the administered dose for at least two weeks. Period of gradual dosage reduction may depend on the dose itself, the duration of treatment and the individual patient.
If you have the impression that the effect of Laroksin is too strong or too weak, talk to your doctor or pharmacist!
If you take too much of the drug:
Accidental ingestion of high doses of prescribed immediately seek help from a doctor!
If you forget to Laroksin SR
If you forget to take the next dose within 12 hours after the last dose, then take it to the next day and resume normal treatment. If it is more than 12 hours to receive and skip the next day to resume normal treatment.
POSSIBLE SIDE EFFECTS
Like all medicines, Laroksin SR can cause side effects
Usually Laroksin SR tolerated. If you experience any adverse reactions should be borne in mind that they usually are not serious and rapid resolution.
If any side effects worry you, keep in mind that they do not occur in any patient. Some of these reactions are very rare.
Given that some of these symptoms are severe or start to bother you, you should tell your doctor: insomnia, rapid Does irregular heartbeat, flushing or redness of the face, decreased, or changes in appetite, constipation, nausea, vomiting, nervousness , nervous agitation, delirium, dizziness, fatigue, difficulty sleeping, abnormal dreams, impotence, drowsiness, muscle rigidity and tremors, unpleasant skin sensations such as "pins and needles" or burning, sweating (including night), rash tinnitus (ringing in the ears), bruxism (teeth grinding unconsciously), pruritus, hair loss, flushing, dry mouth, altered taste sensation, photosensitivity, lung damage known as pulmonary eosinophilia, increased intraocular pressure, loss or weight gain decreased libido, difficulty urinating, diarrhea, bruising, mucosal bleeding, lethargy, hallucinations, severe and prolonged menstruation, hepatitis, seizures, mania, akathisia, neuroleptic malignant syndrome, serotonergic syndrome, pancreatitis, increased prolactin (a hormone produced in the brain) damage to muscle tissue, abnormal movements or muscle tone, severe skin reactions such as Stevens Johnson syndrome and toxic epidermal necrolysis, rash.
You should immediately inform your doctor if you develop an allergic reaction such as skin rash or any other allergic reaction.
Some patients sometimes feel dizzy or unstable upright due to a decrease in blood pressure. In other increases in blood pressure and slight changes in cholesterol and sodium in the blood, abnormal blood cells or alterations in liver function. Sometimes blood pressure increases slightly, so it needs to be monitored, especially in patients who are being treated for high blood pressure.
Very rarely seen rapid heartbeat (tachycardia) and abnormal heart rhythms. Use in children and adolescents under 18 years
Venlafaxine is generally not used to treat children and adolescents under 18 years of age. In clinical studies with drugs of the same group, patients under 18 years were at increased risk of side effects such as suicide attempt, suicidal thoughts and hostility (aggression, conflict behavior and anger) .. Despite ot.tova at the discretion of the physician can to prescribe venlafaxine for the treatment of children and adolescents under 18 years. If your doctor has prescribed venlafaxine for a patient under 18 years, ask him if you want to discuss it. You should tell your doctor if you notice any of these symptoms or deterioration in patients under 18 years receiving venlafaxine. With continued use in patients under 18 years receiving venlafaxine no adverse effects associated with growth, maturation and cognitive and behavioral development. If you notice any side effects not listed in this leaflet, please tell your doctor.